Our team of hundreds of leading cancer physicians and oncology-trained support staff is a trusted partner in returning patients with cancer to good health.
Bone Marrow Transplant
Recognized as one of the leading programs of its kind, UT Southwestern Medical Center’s Bone Marrow Transplant Program has performed more than 1,200 bone marrow transplants (also known as stem cell transplants) while achieving the best one-year patient survival rates in North Texas.
Our highly specialized program is part of the Harold C. Simmons Comprehensive Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in North Texas.
Hematologic Malignancies & Bone Marrow Transplantation Program
The Hematologic Malignancies & Bone Marrow Transplantation Program at UT Southwestern provides excellent, compassionate care for patients with all types of blood cancers. From a personalized patient experience to cutting-edge treatments, discover what sets us apart.
Expert Care and Top Accolades
A bone marrow transplant replaces unhealthy bone marrow – the tissue inside bones that produces blood-forming cells – with healthy cells that should restore normal blood cell production. Bone marrow transplants are used to treat people with cancers of the blood, bone marrow, and lymph nodes, and other blood and immune disorders.
The Bone Marrow Transplant Program at UT Southwestern is accredited by the Foundation for the Accreditation of Cellular Therapy, which recognizes top-quality patient care. We also have been deemed a national center of excellence by all major national health insurance carriers.
Our experienced physicians, nurses, and other care providers guide patients through every step of the bone marrow transplant process. We strive to deliver the most appropriate and effective care possible, and we’re here to manage care from diagnosis to personalized treatment and beyond.
UT Southwestern offers CAR-T therapy for the treatment of leukemia, lymphoma, and myeloma. CAR-T is immunotherapy in which a patient’s T-cells, a type of white blood cell, are genetically modified to include a chimeric antigen receptor (CAR) that is designed to bind to specific proteins on cancer cells. This reprograms the T-cells to recognize and attack the patient’s specific cancer. We are an approved site for Yescarta and Kymriah immunotherapies for the treatment of lymphoma. Kymriah can also be used to treat leukemia. We are one of just nine U.S. hospitals participating in the most advanced phases of clinical trials of CAR-T therapy for multiple myeloma.
At UT Southwestern, we perform bone marrow transplants for patients ranging in age from early adulthood to their 70s.
UT Southwestern’s Bone Marrow Transplant Program is unique because:
- Our team is specially
trained to care for patients with blood cancers and other blood disorders.
- Our specialists are
leading the way in clinical trials related to blood cancers and bone
- We have the leading
survival rate for adult allogeneic stem cell (bone marrow) transplants in Texas.
- We pioneered a
transplant process that replaces harmful cells with immune cells engineered to
attack diseased cells.
- We are experts in
both autologous (patient’s own cells) and allogeneic (donor cells) transplants.
- We offer a variety of support services to help patients and families through bone marrow transplantation and beyond.
Helping Dad beat leukemia: Jon and Chuck’s story
Showing 1 locations